| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Freenome (NASDAQ:FRNM) through any online brokerage.
Other companies in Freenome’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Freenome has a consensus price target of $18.00.
The stock price for Freenome (NASDAQ: FRNM) is $17.2 last updated October 6, 2026 at 7:00 AM EDT.
There are no upcoming dividends for Freenome.
Freenome does not have any upcoming earnings scheduled.
There is no upcoming split for Freenome.
Freenome is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately...